OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Drug Digest: Analytics and Assays Strive to Keep Pace with Innovative Modalities
This episode of Drug Digest explores new and emerging technologies, such as mass photometry, machine learning, and AI, and their role in the analytical space for biologic modalities.
With the evolution of biologic modalities in the drug development pipeline, the biopharma industry understands that it must keep pace with the development and use of appropriate analytics and assays for molecule characterization, to determine product purity, safety, and efficacy, and even early on in the R&D process, where analytics are key in screening multitudes of molecules to determine viable candidates to move into the drug development phases. This episode of Drug Digest explores new and emerging technologies, such as mass photometry, machine learning, and AI, and their role in the analytical space for biologic modalities.
Interviews featuring
Salma Jalal, Product Marketing Manager, Refeyn
As a product marketing manager at Refeyn, Salma supports customers in biopharma and the life sciences to revolutionize their analytical workflows through the use of mass photometry. She holds a PhD in Mechanobiology from the National University of Singapore and has over a decade of technical expertise in the application of microscopy techniques to study biological systems. She has a particular interest in the analysis of biologics and is very happy to discuss all things biomolecular characterization.
Philipp Lorenz, PhD, Chief Technology Officer, Basecamp Research
Philipp Lorenz, PhD, is the chief technology officer (CTO) of Basecamp Research, based in London. He attended the University of Oxford from 2012 to 2016, where he co-founded the first iGEM team from Oxford alongside Glen Gowers, the CEO and co-founder, of Basecamp Research. Lorenz gained a Masters degree in Biochemistry and a PhD from Oxford in Genetics and Bioinformatics. He was a tutor at the institution, teaching Computational Biology, Statistics, and Genetics to undergraduate and graduate students. Previously the head of Data Science at Basecamp Research, Lorenz became the CTO in May 2022 and is driven by his passion to build the next generation of life science artificial intelligence solutions fueled by better data and deeper knowledge about life on earth.
Sponsors
This episode of Drug Digest is sponsored by:
- Kindeva
About Drug Digest
Drug Digest is a tech talk video series with the Pharmaceutical Technology® editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.
Upcoming episodes
- July 2024: Biopharma Drug Development and Manufacturing
- August 2024: Aseptic Processing and Manufacturing
- September 2024: Small Molecule APIs, Excipients, and Formulation
